Reply to comment

Plus podcast 22, February 2010: Evaluating a medical treatment

New treatments and drugs are tested extensively before they come on the market using randomised controlled trials (RCTs). We talk to David Spiegelhalter (Winton Professor of the Public Understanding of Risk), Sheila Bird (Professor at the Medical Research Council Biostatistics Unit), and Nigel Hawkes (journalist and director of Straight Statistics) about why RCTs are used and how they test if a new treatment works. You can also read an accompanying article.


Plus podcast 22, February 2010: Evaluating a medical treatment

Reply

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options

To prevent automated spam submissions leave this field empty.
By submitting this form, you accept the Mollom privacy policy.